ArticleJournal of pharmacokinetics and pharmacodynamics2019

Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients.

Sophie E Berends et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.